The year we're about to leave - for some, maybe forget - saw several noteworthy business-related events in Central Massachusetts, but here's our consensus selections for the top five stories of 2014. As a staff, we unanimously agreed on the top story. There was little debate over the remaining four.
There was more optimism among Central Massachusetts business leaders heading into 2014. There's even more heading into 2015. Here are the results of this year's Economic Forecast survey, along with out predictions for the year ahead and our report card on how our predictions for 2014 turned out.
Marlborough-based biotechnology firm RXi Pharmaceuticals said three-month observations have confirmed the effectiveness of its first product candidate, RXI-109, in the treatment of post-surgical scars.
Boston Scientific of Marlborough suffered a rough month in the legal system in November after two federal court juries awarded more than $45 million to eight women who claimed injuries from the medical device manufacturer's transvaginal mesh devices. What do they mean for the company?
Affordable Interior Systems, Inc. of Leominster, Quest Diagnostics of Marlborough, and Pall Life Sciences of Westborough were among 18 companies from across the state honored by MassEcon this week for their contributions to the economy.
Sunovion Pharmaceuticals Inc. of Marlborough has submitted a supplemental new drug application to the Food and Drug Administration. The application seeks approval for the use of Aptiom for monotherapy treatment of partial-onset seizures in patients with epilepsy.